Walter Pirker Selected Research

2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)

12/2004	Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's disease.
11/2003	Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.
1/2003	Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding.
1/2003	Camptocormia in idiopathic Parkinson's disease: [(123)I]beta-CIT SPECT and clinical characteristics.
7/2002	Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
5/2002	[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
1/2002	Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter Pirker Research Topics

Disease

20	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2002
4	Parkinsonian Disorders (Parkinsonism) 12/2014 - 01/2002
3	Multiple System Atrophy 01/2018 - 01/2012
3	Tremor (Tremors) 08/2017 - 04/2003
2	Dyskinesias (Dyskinesia) 09/2018 - 08/2017
2	Dementia (Dementias) 10/2015 - 09/2014
2	Corticobasal Degeneration 01/2015 - 02/2013
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2009 - 12/2008
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Immunoglobulin G4-Related Disease 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Myasthenia Gravis 01/2021
1	Tardive Dyskinesia 09/2016
1	Frontotemporal Dementia (Semantic Dementia) 10/2015
1	Sarcoma (Soft Tissue Sarcoma) 10/2015
1	Lewy Body Disease (Lewy Body Dementia) 10/2015
1	Alzheimer Disease (Alzheimer's Disease) 10/2015
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2014
1	Gliosis 09/2014
1	Synucleinopathies 09/2014
1	Camptocormia 01/2003
1	Tourette Syndrome (Tourette's Syndrome) 07/2002
1	Mental Disorders (Mental Disorder) 07/2002
1	Bulimia (Binge Eating) 07/2002
1	Schizophrenia (Dementia Praecox) 07/2002
1	Disease Progression 01/2002
1	Essential Tremor (Essential Tremors) 01/2002

Drug/Important Bio-Agent (IBA)

7	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 12/2004 - 01/2002
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2015 - 07/2002
3	SynucleinsIBA 01/2018 - 09/2014
2	Levodopa (L Dopa)FDA LinkGeneric 09/2018 - 04/2003
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2009 - 12/2008
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2009 - 07/2002
2	Serotonin (5 Hydroxytryptamine)IBA 12/2008 - 07/2002
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	Coffee FDA Link 01/2022
1	AntibodiesIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	TabletsIBA 08/2017
1	Antipsychotic Agents (Antipsychotics)IBA 09/2016
1	Amyloid (Amyloid Fibrils)IBA 10/2015
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2015
1	GranulinsIBA 10/2015
1	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Glucosylceramidase (Glucocerebrosidase)IBA 04/2013
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 02/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 08/2012
1	Cetirizine (Zyrtec)FDA LinkGeneric 01/2012
1	Transcription Factors (Transcription Factor)IBA 02/2011
1	Clomipramine (Anafranil)FDA LinkGeneric 12/2008
1	Citalopram FDA LinkGeneric 12/2008
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 04/2003
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2003
1	LigandsIBA 07/2002
1	Pharmaceutical PreparationsIBA 07/2002
1	Biological ProductsIBA 07/2002
1	5-HT1A Serotonin ReceptorIBA 07/2002
1	Psychotropic Drugs (Psychoactive Drugs)IBA 07/2002
1	Dopamine (Intropin)FDA LinkGeneric 01/2002

Therapy/Procedure

3	Therapeutics 11/2019 - 08/2017
3	Deep Brain Stimulation 11/2019 - 01/2017
1	Activities of Daily Living (ADL) 11/2019
1	Aftercare (After-Treatment) 12/2008
1	Denervation 10/2003